Cargando…

Medical Costs Associated with Insomnia Treatment with Suvorexant Monotherapy in Japan: Results from a Retrospective Cohort Study Using a Large-Scale Claims Database

BACKGROUND: The association of insomnia treatment with medical costs is not well characterized in Japan, despite the high economic burden of insomnia. OBJECTIVE: The aim of this study was to investigate the impact of suvorexant, the first dual orexin receptor antagonist, on direct medical costs in i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uchiyama, Makoto, Ito, Kaoru, Okumura, Yasuyuki, Yi, Jingbo, Crawford, Bruce, Abe, Machiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114234/ https://www.ncbi.nlm.nih.gov/pubmed/35129832 http://dx.doi.org/10.1007/s40801-021-00279-y

Ejemplares similares

Profile of suvorexant in the management of insomnia
por: Sutton, Eliza L
Publicado: (2015)

Suvorexant: a promising, novel treatment for insomnia
por: Lee-Iannotti, Joyce K, et al.
Publicado: (2016)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

Suvorexant for insomnia in older adults: a perspective review
por: Tampi, Rajesh R, et al.
Publicado: (2018)

Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant
por: Kale, Hrishikesh P., et al.
Publicado: (2021)

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
por: Hatano, Masakazu, et al.
Publicado: (2018)

Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study
por: Kishi, Taro, et al.
Publicado: (2019)

Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database
por: Okuda, Shoki, et al.
Publicado: (2023)

Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus
por: Toi, Norikazu, et al.
Publicado: (2018)

Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
por: Norman, Jessica L, et al.
Publicado: (2016)

2420 Examining characteristics of placebo effects on trauma-related insomnia in a suvorexant trial
por: Uweh, Kimberly
Publicado: (2018)

Nationwide claims database analysis of treatment patterns, costs and survival of Japanese patients with diffuse large B-cell lymphoma
por: Tsutsué, Saaya, et al.
Publicado: (2020)

Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
por: Kishi, Taro, et al.
Publicado: (2015)

Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
por: Herring, W. Joseph, et al.
Publicado: (2020)

Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure
por: Ito, Hiroshi, et al.
Publicado: (2021)

Psychiatric Admissions and Length of Stay During Fiscal Years 2014 and 2015 in Japan: A Retrospective Cohort Study Using a Nationwide Claims Database
por: Okumura, Yasuyuki, et al.
Publicado: (2019)

Characteristics of 2-drug regimen users living with HIV-1 in a real-world setting: A large-scale medical claim database analysis in Japan
por: Ruzicka, Daniel J., et al.
Publicado: (2022)

Suvorexant for the prevention of delirium: A meta-analysis
por: Xu, Shu, et al.
Publicado: (2020)

Single-use suvorexant for treating insomnia during overnight polysomnography in patients with suspected obstructive sleep apnea: a single-center experience
por: Matsumura, Takuma, et al.
Publicado: (2019)

Epidemiology of overdose episodes from the period prior to hospitalization for drug poisoning until discharge in Japan: An exploratory descriptive study using a nationwide claims database
por: Okumura, Yasuyuki, et al.
Publicado: (2017)

Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan
por: Tokunaga, Kengo, et al.
Publicado: (2021)

Treatment Status and Healthcare Cost Trends for Patients with Multiple Sclerosis in Japan: A Claims Database Analysis
por: Kawachi, Izumi, et al.
Publicado: (2022)

Validation study of case-identifying algorithms for severe hypoglycemia using hospital administrative data in Japan
por: Osaga, Satoshi, et al.
Publicado: (2023)

Distinct effects of IPSU and suvorexant on mouse sleep architecture
por: Hoyer, Daniel, et al.
Publicado: (2013)

Is suvorexant a better choice than alternative hypnotics?
por: Kripke, Daniel F.
Publicado: (2015)

PT653. Experience using suvorexant to treat delirium
por: Fujiwara, Kodo, et al.
Publicado: (2016)

(82) Effect of Suvorexant on COVID-19 Associated Delirium
por: Nazeer, Sahana, et al.
Publicado: (2022)

Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database
por: Okuda, Shoki, et al.
Publicado: (2023)

Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Ogino, Mieko, et al.
Publicado: (2017)

Clinical characteristics in patients with non-alcoholic steatohepatitis in Japan: a case–control study using a 5-year large-scale claims database
por: Tokutsu, Kei, et al.
Publicado: (2023)

Dual orexin receptor antagonists for treatment of insomnia: A systematic review and meta-analysis on randomized, double-blind, placebo-controlled trials of suvorexant and lemborexant
por: Khazaie, Habibolah, et al.
Publicado: (2022)

Suvorexant improves intractable nocturnal enuresis by altering sleep architecture
por: Matsumoto, Tohru
Publicado: (2021)

Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database
por: Hamada, Shota, et al.
Publicado: (2015)

Suvorexant (Belsomra(®) Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey
por: Asai, Yuko, et al.
Publicado: (2018)

The burden of insomnia in Japan
por: Mishima, Kazuo, et al.
Publicado: (2015)

Actual state of “triple therapy” for heart failure patients in eight regions of Japan: An analysis of a nationwide medical claims database
por: Abe, Daisuke, et al.
Publicado: (2021)

Temporal trends of medical cost and cost-effectiveness in sepsis patients: a Japanese nationwide medical claims database
por: Oami, Takehiko, et al.
Publicado: (2022)

Shaping suvorexant: application of experimental and theoretical methods for driving synthetic designs
por: McGaughey, Georgia, et al.
Publicado: (2014)

Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant
por: Booka, Eisuke, et al.
Publicado: (2017)

How are new drugs disseminated in Japan? Analysis using the National Database of Health Insurance Claims of Japan
por: Watanabe, Tomone, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7o2pmo63adqkp3asjikqgb7d60